Cargando…
An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis
Non-selective inhibitors of spleen tyrosine kinase (SYK) efficiently suppress disease in T cell-dependent models of crescentic glomerulonephritis. However, the therapeutic potential of selective SYK inhibitors in this disease has not been established. In addition, we lack knowledge regarding SYK exp...
Autores principales: | Han, Yingjie, Ma, Frank Y, Di Paolo, Julie, Nikolic-Paterson, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024518/ https://www.ncbi.nlm.nih.gov/pubmed/29923438 http://dx.doi.org/10.1177/2058738418783404 |
Ejemplares similares
-
ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis
por: Amos, Liv A., et al.
Publicado: (2018) -
Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014) -
Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017) -
Crescentic glomerulonephritis in children
por: Mayer, Ulrike, et al.
Publicado: (2020) -
Membranous Glomerulonephritis With Crescents
por: Nikolopoulou, Aikaterini, et al.
Publicado: (2019)